1. A prospective, phase II trial of monotherapy with low-dose afatinib for patients with EGFR, mutation-positive, non-small cell lung cancer: Thoracic oncology research group 1632. (November 2021) Authors: Noro, Rintaro; Igawa, Satoshi; Bessho, Akihiro; Hirose, Takashi; Shimokawa, Tsuneo; Nakashima, Masanao; Minato, Koichi; Seki, Nobuhiko; Tokito, Takaaki; Harada, Toshiyuki; Sasada, Shinji; Miyamoto, Shingo; Tanaka, Yosuke; Furuya, Naoki; Kaburagi, Takayuki; Hayashi, Hideki; Iihara, Hirotoshi; Okam... Journal: Lung cancer Issue: Volume 161(2021) Page Start: 49 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Assessment of chemotherapy regimens on radiation pneumonitis in patients with unresectable stage III non‐small‐cell lung cancer after definitive chemoradiotherapy. Issue 13 (18th May 2021) Authors: Sakaguchi, Tadashi; Ito, Kentaro; Furuya, Naoki; Morikawa, Kei; Fujiwara, Kentaro; Nishii, Yoichi; Inoue, Takeo; Hataji, Osamu; Mineshita, Masamichi Journal: Thoracic cancer Issue: Volume 12:Issue 13(2021) Page Start: 2024 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Bevacizumab plus erlotinib versus erlotinib alone in Japanese patients with advanced, metastatic, EGFR-mutant non-small-cell lung cancer (NEJ026): overall survival analysis of an open-label, randomised, multicentre, phase 3 trial. Issue 1 (January 2022) Authors: Kawashima, Yosuke; Fukuhara, Tatsuro; Saito, Haruhiro; Furuya, Naoki; Watanabe, Kana; Sugawara, Shunichi; Iwasawa, Shunichiro; Tsunezuka, Yoshio; Yamaguchi, Ou; Okada, Morihito; Yoshimori, Kozo; Nakachi, Ichiro; Seike, Masahiro; Azuma, Koichi; Kurimoto, Futoshi; Tsubata, Yukari; Fujita, Yuka; Nag... Journal: Lancet Issue: Volume 10:Issue 1(2022) Page Start: 72 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Cell therapy with adipose tissue-derived stem/stromal cells for elastase-induced pulmonary emphysema in rats. (July 2012) Authors: Furuya, Naoki; Takenaga, Mitsuko; Ohta, Yuki; Tokura, Yukie; Hamaguchi, Akemi; Sakamaki, Aya; Kida, Hirotaka; Handa, Hiroshi; Nishine, Hiroki; Mineshita, Masamichi; Miyazawa, Teruomi Journal: Regenerative medicine Issue: Volume 7:Number 4(2012) Page Start: 503 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Combining PD-L1 Expression and Standardized Uptake Values in FDG-PET/CT Can Predict Prognosis in Patients With Resectable Non–Small-Cell Lung Cancer. (11th August 2021) Authors: Miyazawa, Tomoyuki; Otsubo, Kanji; Sakai, Hiroki; Kimura, Hiroyuki; Chosokabe, Motohiro; Morikawa, Kei; Furuya, Naoki; Marushima, Hideki; Kojima, Koji; Mineshita, Masamichi; Koike, Junki; Saji, Hisashi Journal: Cancer control Issue: Volume 28(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Comprehensive assessment of PD-L1 expression, tumor mutational burden and oncogenic driver alterations in non-small cell lung cancer patients treated with immune checkpoint inhibitors. (September 2021) Authors: Yoh, Kiyotaka; Matsumoto, Shingo; Furuya, Naoki; Nishino, Kazumi; Miyamoto, Shingo; Oizumi, Satoshi; Okamoto, Norio; Itani, Hidetoshi; Kuyama, Shoichi; Nakamura, Atsushi; Nishi, Koichi; Fukuda, Ikue; Tsuta, Koji; Hayashi, Yuichiro; Motoi, Noriko; Ishii, Genichiro; Goto, Koichi Journal: Lung cancer Issue: Volume 159(2021) Page Start: 128 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Current status of clinical proteogenomics in lung cancer. (2nd September 2019) Authors: Nishimura, Toshihide; Nakamura, Haruhiko; Végvári, Ákos; Marko-Varga, György; Furuya, Naoki; Saji, Hisashi Journal: Expert review of proteomics Issue: Volume 16:Number 9(2019) Page Start: 761 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Development of micro‐inclined well array for trapping single cells. Issue 10 (20th July 2018) Authors: Tsukamoto, Takuya; Furuya, Naoki; Shimagami, Takuya; Sato, Rui; Shimokawa, Fusao; Akimitsu, Kazuya; Suzuki, Takaaki Journal: Electronics and communications in Japan Issue: Volume 101:Issue 10(2018) Page Start: 45 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Differences in skeletal muscle loss caused by cytotoxic chemotherapy and molecular targeted therapy in patients with advanced non‐small cell lung cancer. Issue 1 (25th October 2017) Authors: Kakinuma, Kazutaka; Tsuruoka, Hazime; Morikawa, Kei; Furuya, Naoki; Inoue, Takeo; Miyazawa, Teruomi; Mineshita, Masamichi Journal: Thoracic cancer Issue: Volume 9:Issue 1(2018) Page Start: 99 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Disseminated erythema with intense and selective inflammation of sweat gland and lichenoid drug eruption during nivolumab therapy. Issue 2 (6th October 2017) Authors: Matsumoto, Yukio; Kadono, Takafumi; Matsuoka, Maya; Kawakami, Tamihiro; Furuya, Naoki; Doi, Masatomo; Hoshikawa, Masahiro; Soma, Yoshinao Journal: Journal of dermatology Issue: Volume 45:Issue 2(2018) Page Start: e33 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗